Document is current
Any future updates will be listed below
-
Authors
Huang, Yu-Hwa
Yoon, Charles H.
Gandhi, Amit https://orcid.org/0000-0003-0654-1097
Hanley, Thomas
Castrillon, Carlos
Kondo, Yasuyuki
Lin, Xi
Kim, Walter
Yang, Chao
Driouchi, Amine
Carroll, Michael https://orcid.org/0000-0002-3213-4295
Gray-Owen, Scott D. https://orcid.org/0000-0002-1477-3616
Wesemann, Duane R. https://orcid.org/0000-0002-6690-944X
Drake, Charles G. https://orcid.org/0000-0001-9610-3677
Bertagnolli, Monica M.
Beauchemin, Nicole
Blumberg, Richard S. https://orcid.org/0000-0002-9704-248X
- License Information
-
More Information
Article History
Received: 24 April 2023
Accepted: 8 May 2024
First Online: 2 July 2024
Competing interests
: R.S.B. and Y.-H.H. are inventors on patent US 2017/0327578 describing the 26H7 monoclonal antibody. R.S.B., Y.-H.H., A.G., C.H.Y., and M.M.B. are inventors of other patents related to CEACAM1 and cancer immunotherapy (WO 2020/118295). All other authors declare no competing interests.
